company background image
KEQU logo

Kewaunee Scientific NasdaqGM:KEQU Stock Report

Last Price

US$33.12

Market Cap

US$95.2m

7D

2.2%

1Y

115.5%

Updated

27 Mar, 2024

Data

Company Financials

Kewaunee Scientific Corporation

NasdaqGM:KEQU Stock Report

Market Cap: US$95.2m

KEQU Stock Overview

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.

KEQU fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends0/6

Kewaunee Scientific Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kewaunee Scientific
Historical stock prices
Current Share PriceUS$33.12
52 Week HighUS$33.90
52 Week LowUS$14.56
Beta0.67
1 Month Change17.45%
3 Month Change13.46%
1 Year Change115.48%
3 Year Change168.40%
5 Year Change58.39%
Change since IPO117.18%

Recent News & Updates

Recent updates

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02
Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Mar 10
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Sep 08

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Jun 30

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Apr 12
Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Dec 28
Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Kewaunee Scientific reports Q2 results

Dec 09

Shareholder Returns

KEQUUS Medical EquipmentUS Market
7D2.2%2.2%0.4%
1Y115.5%13.3%28.8%

Return vs Industry: KEQU exceeded the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: KEQU exceeded the US Market which returned 29.5% over the past year.

Price Volatility

Is KEQU's price volatile compared to industry and market?
KEQU volatility
KEQU Average Weekly Movement4.7%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: KEQU's share price has been volatile over the past 3 months.

Volatility Over Time: KEQU's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1906982Thomas Hullhttps://www.kewaunee.com

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Kewaunee Scientific Corporation Fundamentals Summary

How do Kewaunee Scientific's earnings and revenue compare to its market cap?
KEQU fundamental statistics
Market capUS$95.22m
Earnings (TTM)US$8.73m
Revenue (TTM)US$201.04m

10.9x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KEQU income statement (TTM)
RevenueUS$201.04m
Cost of RevenueUS$153.27m
Gross ProfitUS$47.77m
Other ExpensesUS$39.04m
EarningsUS$8.73m

Last Reported Earnings

Jan 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)3.04
Gross Margin23.76%
Net Profit Margin4.34%
Debt/Equity Ratio69.4%

How did KEQU perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.